TScan Therapeutics (TCRX) Current Deferred Tax Assets (2021)
Historic Current Deferred Tax Assets for TScan Therapeutics (TCRX) over the last 1 years, with Q2 2021 value amounting to $2.5 million.
Historic Current Deferred Tax Assets for TScan Therapeutics (TCRX) over the last 1 years, with Q2 2021 value amounting to $2.5 million.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month